This is disappointing news... as this currently in clinical trials here in the USA!
Seikagaku Halts Development of New Interstitial Cystitis Drug
Tokyo (JCNN) - Seikagaku has announced that it has decided to halt the development of "SI-7201," a drug candidate for treatment of interstitial cystitis, which is currently under clinical testing in the US. Having made this decision, the company has also dissolved its alliance with Nippon Shinyaku regarding the collaborative development and distribution of the drug in Japan. SI-7201 is a Sodium Hyaluronate product.
Jill
Seikagaku Halts Development of New Interstitial Cystitis Drug
Tokyo (JCNN) - Seikagaku has announced that it has decided to halt the development of "SI-7201," a drug candidate for treatment of interstitial cystitis, which is currently under clinical testing in the US. Having made this decision, the company has also dissolved its alliance with Nippon Shinyaku regarding the collaborative development and distribution of the drug in Japan. SI-7201 is a Sodium Hyaluronate product.
Jill
Comment